Copyright Reports & Markets. All rights reserved.

Global Viral and Non-Viral Vector Manufacturing Market Opportunities and Forecast 2022-2028

Request for Sample of this report
Buy now

Table of Contents

    1 Product Introduction and Overview

    • 1.1 Product Definition
    • 1.2 Product Specification
    • 1.3 Global Market Overview
      • 1.3.1 Global Viral and Non-Viral Vector Manufacturing Market Status and Forecast (2017-2028)
      • 1.3.2 Global Viral and Non-Viral Vector Manufacturing Sales Value CAGR by Region
    • 1.4 Market Drivers, Inhibitors
      • 1.4.1 Market Drivers
      • 1.4.2 Market Inhibitors
      • 1.4.3 COVID-19 Impact Analysis

    2 Global Viral and Non-Viral Vector Manufacturing Supply by Company

    • 2.1 Global Viral and Non-Viral Vector Manufacturing Sales Value by Company
    • 2.2 Viral and Non-Viral Vector Manufacturing Sales Area of Main Manufacturers
    • 2.3 Trend of Concentration Rate

    3 Global and Regional Viral and Non-Viral Vector Manufacturing Market Status by Type

    • 3.1 Viral and Non-Viral Vector Manufacturing Type Introduction
      • 3.1.1 Viral Vectors
      • 3.1.2 Non-Viral Vectors
    • 3.2 Global Viral and Non-Viral Vector Manufacturing Market by Type
    • 3.3 North America: by Type
    • 3.4 Europe: by Type
    • 3.5 Asia Pacific: by Type
    • 3.6 Central & South America: by Type
    • 3.7 Middle East & Africa: by Type

    4 Global and Regional Viral and Non-Viral Vector Manufacturing Market Status by Application

    • 4.1 Viral and Non-Viral Vector Manufacturing Segment by Application
      • 4.1.1 Gene Therapy
      • 4.1.2 Vaccinology
      • 4.1.3 Cell Therapy
      • 4.1.4 Others
    • 4.2 Global Viral and Non-Viral Vector Manufacturing Market by Application
    • 4.3 North America: by Application
    • 4.4 Europe: by Application
    • 4.5 Asia Pacific: by Application
    • 4.6 Central & South America: by Application
    • 4.7 Middle East & Africa: by Application

    5 Global Viral and Non-Viral Vector Manufacturing Market Status by Region

    • 5.1 Global Viral and Non-Viral Vector Manufacturing Market by Region
    • 5.2 North America Viral and Non-Viral Vector Manufacturing Market Status
    • 5.3 Europe Viral and Non-Viral Vector Manufacturing Market Status
    • 5.4 Asia Pacific Viral and Non-Viral Vector Manufacturing Market Status
    • 5.5 Central & South America Viral and Non-Viral Vector Manufacturing Market Status
    • 5.6 Middle East & Africa Viral and Non-Viral Vector Manufacturing Market Status

    6 North America Viral and Non-Viral Vector Manufacturing Market Status

    • 6.1 North America Viral and Non-Viral Vector Manufacturing Market by Country
    • 6.2 United States
    • 6.3 Canada
    • 6.4 Mexico

    7 Europe Viral and Non-Viral Vector Manufacturing Market Status

    • 7.1 Europe Viral and Non-Viral Vector Manufacturing Market by Country
    • 7.2 Germany
    • 7.3 France
    • 7.4 UK
    • 7.5 Italy
    • 7.6 Russia
    • 7.7 Spain

    8 Asia Pacific Viral and Non-Viral Vector Manufacturing Market Status

    • 8.1 Asia Pacific Viral and Non-Viral Vector Manufacturing Market by Country
    • 8.2 China
    • 8.3 Japan
    • 8.4 Korea
    • 8.5 Southeast Asia
    • 8.6 India
    • 8.7 Australasia

    9 Central & South America Viral and Non-Viral Vector Manufacturing Market Status

    • 9.1 Central & South America Viral and Non-Viral Vector Manufacturing Market by Country
    • 9.2 Brazil
    • 9.3 Argentina
    • 9.4 Colombia

    10 Middle East & Africa Viral and Non-Viral Vector Manufacturing Market Status

    • 10.1 Middle East & Africa Viral and Non-Viral Vector Manufacturing Market by Country
    • 10.2 Iran
    • 10.3 Israel
    • 10.4 Turkey
    • 10.5 South Africa
    • 10.8 Saudi Arabia

    11 Major Downstream Customers Analysis

    • 11.1 Customer One Analysis
    • 11.2 Customer Two Analysis
    • 11.3 Customer Three Analysis
    • 11.4 Customer Four Analysis

    12 Global Viral and Non-Viral Vector Manufacturing Market Forecast by Type and by Application

    • 12.1 Global Viral and Non-Viral Vector Manufacturing Sales Value Forecast (2023-2028)
    • 12.2 Global Viral and Non-Viral Vector Manufacturing Forecast by Type
    • 12.3 Global Viral and Non-Viral Vector Manufacturing Forecast by Application

    13 Global Viral and Non-Viral Vector Manufacturing Market Forecast by Region/Country

    • 13.1 Global Viral and Non-Viral Vector Manufacturing Market Forecast by Region (2023-2028)
    • 13.2 North America Market Forecast
    • 13.3 Europe Market Forecast
    • 13.4 Asia Pacific Market Forecast
    • 13.5 Central & South America Market Forecast
    • 13.6 Middle East & Africa Market Forecast

    14 Key Participants Company Information

    • 14.1 Wuxi AppTec
      • 14.1.1 Company Information
      • 14.1.2 Viral and Non-Viral Vector Manufacturing Product Introduction
      • 14.1.3 Wuxi AppTec Viral and Non-Viral Vector Manufacturing Sales Value, Gross Margin and Global Share (2020-2022)
      • 14.1.4 SWOT Analysis
    • 14.2 Thermo Fisher Scientific Inc.
      • 14.2.1 Company Information
      • 14.2.2 Viral and Non-Viral Vector Manufacturing Product Introduction
      • 14.2.3 Thermo Fisher Scientific Inc. Viral and Non-Viral Vector Manufacturing Sales Value, Gross Margin and Global Share (2020-2022)
      • 14.2.4 SWOT Analysis
    • 14.3 Takara Bio Inc.
      • 14.3.1 Company Information
      • 14.3.2 Viral and Non-Viral Vector Manufacturing Product Introduction
      • 14.3.3 Takara Bio Inc. Viral and Non-Viral Vector Manufacturing Sales Value, Gross Margin and Global Share (2020-2022)
      • 14.3.4 SWOT Analysis
    • 14.4 T&T Scientific Corporation
      • 14.4.1 Company Information
      • 14.4.2 Viral and Non-Viral Vector Manufacturing Product Introduction
      • 14.4.3 T&T Scientific Corporation Viral and Non-Viral Vector Manufacturing Sales Value, Gross Margin and Global Share (2020-2022)
      • 14.4.4 SWOT Analysis
    • 14.5 Sartorius AG
      • 14.5.1 Company Information
      • 14.5.2 Viral and Non-Viral Vector Manufacturing Product Introduction
      • 14.5.3 Sartorius AG Viral and Non-Viral Vector Manufacturing Sales Value, Gross Margin and Global Share (2020-2022)
      • 14.5.4 SWOT Analysis
    • 14.6 Oxford Biomedica Plc
      • 14.6.1 Company Information
      • 14.6.2 Viral and Non-Viral Vector Manufacturing Product Introduction
      • 14.6.3 Oxford Biomedica Plc Viral and Non-Viral Vector Manufacturing Sales Value, Gross Margin and Global Share (2020-2022)
      • 14.6.4 SWOT Analysis
    • 14.7 Moderna, Inc.
      • 14.7.1 Company Information
      • 14.7.2 Viral and Non-Viral Vector Manufacturing Product Introduction
      • 14.7.3 Moderna, Inc. Viral and Non-Viral Vector Manufacturing Sales Value, Gross Margin and Global Share (2020-2022)
      • 14.7.4 SWOT Analysis
    • 14.8 Merck KGaA Inc.
      • 14.8.1 Company Information
      • 14.8.2 Viral and Non-Viral Vector Manufacturing Product Introduction
      • 14.8.3 Merck KGaA Inc. Viral and Non-Viral Vector Manufacturing Sales Value, Gross Margin and Global Share (2020-2022)
      • 14.8.4 SWOT Analysis
    • 14.9 Lonza Group AG
      • 14.9.1 Company Information
      • 14.9.2 Viral and Non-Viral Vector Manufacturing Product Introduction
      • 14.9.3 Lonza Group AG Viral and Non-Viral Vector Manufacturing Sales Value, Gross Margin and Global Share (2020-2022)
      • 14.9.4 SWOT Analysis
    • 14.10 Genscript Biotech Corporation
      • 14.10.1 Company Information
      • 14.10.2 Viral and Non-Viral Vector Manufacturing Product Introduction
      • 14.10.3 Genscript Biotech Corporation Viral and Non-Viral Vector Manufacturing Sales Value, Gross Margin and Global Share (2020-2022)
      • 14.10.4 SWOT Analysis
    • 14.11 Genevant Sciences GmbH
    • 14.12 FUJIFILM Holdings Corporation
    • 14.13 Exelead, Inc.
    • 14.14 Evonik Industries AG
    • 14.15 Entos Pharmaceuticals
    • 14.16 Danaher Corporation
    • 14.17 CureVac N.V.
    • 14.18 Catalent, Inc.
    • 14.19 Boehringer Ingelheim
    • 14.20 Acuitas Therapeutics

    15 Conclusion

      16 Methodology

      This report provides a comprehensive analysis of current global Viral and Non-Viral Vector Manufacturing market based on segmented types and downstream applications. Major product development trends are discussed under major downstream segment scenario.This report also focuses on major driving factors and inhibitors that affect the market and competitive landscape. Global and regional leading players in the Viral and Non-Viral Vector Manufacturing industry are profiled in a detailed way, with sales data and market share info. This report also includes global and regional market size and forecast, drill-down to top 20 economies.

      According to this survey, the global Viral and Non-Viral Vector Manufacturing market is estimated at $ million in 2021, and projected to grow at a CAGR of % to $ million by 2028.

      Covid-19 pandemic has impacted the supply and demand status for many industries along the supply chain. Global Viral and Non-Viral Vector Manufacturing Market Opportunities and Forecast 2023-2028 report makes a brilliant attempt to unveil key opportunities available in the global Viral and Non-Viral Vector Manufacturing market under the Covid-19 impact to help readers in achieving a better market position. No matter the client is industry insider, potential entrant or investor, the report will provide useful data and information.

      The Global Viral and Non-Viral Vector Manufacturing Market has been exhibited in detail in the following chapters
      Chapter 1 displays the basic product introduction and market overview.
      Chapter 2 provides the competition landscape of global Viral and Non-Viral Vector Manufacturing industry.
      Chapter 3 provides the market analysis by type and by region
      Chapter 4 provides the market analysis by application and by region
      Chapter 5-10 presents regional and country market size and forecast, under the context of market drivers and inhibitors analysis.
      Chapter 11 analyses the supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis.
      Chapter 12 provides the market forecast by type and by application
      Chapter 13 provides the market forecast by region
      Chapter 14 profies global leading players with their revenue, market share, profit margin, major product portfolio and SWOT analysis.
      Chapter 15 conclusions

      Segmented by Type
      Viral Vectors
      Non-Viral Vectors

      Segmented by Application
      Gene Therapy
      Vaccinology
      Cell Therapy
      Others

      Segmented by Country
      North America
      United States
      Canada
      Mexico
      Europe
      Germany
      France
      UK
      Italy
      Russia
      Spain
      Asia Pacific
      China
      Japan
      Korea
      Southeast Asia
      India
      Australasia
      Central & South America
      Brazil
      Argentina
      Colombia
      Middle East & Africa
      Iran
      Israel
      Turkey
      South Africa
      Saudi Arabia

      Key manufacturers included in this survey
      Wuxi AppTec
      Thermo Fisher Scientific Inc.
      Takara Bio Inc.
      T&T Scientific Corporation
      Sartorius AG
      Oxford Biomedica Plc
      Moderna, Inc.
      Merck KGaA Inc.
      Lonza Group AG
      Genscript Biotech Corporation
      Genevant Sciences GmbH
      FUJIFILM Holdings Corporation
      Exelead, Inc.
      Evonik Industries AG
      Entos Pharmaceuticals
      Danaher Corporation
      CureVac N.V.
      Catalent, Inc.
      Boehringer Ingelheim
      Acuitas Therapeutics
      Buy now